Pers TH, Timshel P, Ripke S, et al. Comprehensive analysis of schizophrenia-associated loci highlights ion channel pathways and biologically plausible candidate causal genes. Hum Mol Genet. 2016;25(6):1247-54. doi:10.1093/hmg/ddw007
Scolnick E. Program to improve cognitive functioning in patients with schizophrenia: reflections. Schizophr Res. 2004;72(1):75-7. doi:10.1016/j.schres.2004.09.005
Bergen SE, O’Dushlaine CT, Lee PH, et al. Genetic modifiers and subtypes in schizophrenia: investigations of age at onset, severity, sex and family history. Schizophr Res. 2014;154(1-3):48-53. doi:10.1016/j.schres.2014.01.030
Siegert S, Seo J, Kwon EJ, et al. The schizophrenia risk gene product miR-137 alters presynaptic plasticity. Nat Neurosci. 2015;18(7):1008-16. doi:10.1038/nn.4023
Sekar A, Bialas AR, de Rivera H, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530(7589):177-83. doi:10.1038/nature16549
Bergen SE, Petryshen TL. Genome-wide association studies of schizophrenia: does bigger lead to better results?. Curr Opin Psychiatry. 2012;25(2):76-82. doi:10.1097/YCO.0b013e32835035dd
Hyman SE. Time for new schizophrenia Rx. Science. 2014;343(6176):1177. doi:10.1126/science.1252603
Pocklington AJ, Rees E, Walters JTR, et al. Novel Findings from CNVs Implicate Inhibitory and Excitatory Signaling Complexes in Schizophrenia. Neuron. 2015;86(5):1203-14. doi:10.1016/j.neuron.2015.04.022
Franke B, Stein JL, Ripke S, et al. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat Neurosci. 2016;19(3):420-31. doi:10.1038/nn.4228
Talkowski ME, Rosenfeld JA, Blumenthal I, et al. Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries. Cell. 2012;149(3):525-37. doi:10.1016/j.cell.2012.03.028